In Head-and-neck and lung tumor models, cancer vaccine immunization can drive local CXCL16 upregulation, CXCR6 expression on TRM precursors, and robust TRM recruitment, while impaired TRM cell seeding was observed in CXCR6-deficient mice [16]. The gene discussed is CXCL16; the disease is cancer.